Redefining heart transplant care: How donor-derived cell-free DNA is transforming rejection surveillance
This webinar highlights the DEFINE-HT study initial results and the two-threshold algorithm: fraction + DQS.
Watch Video
Organ Health
Resources related to tests that help assess undetected rejection event of transplanted organ.
-
-
Surveillance Donor-derived Cell-free DNA Allows for the Safe Reduction in Protocol Transbronchial Biopsies After Lung Transplantation
Kashika Goyal, et al. Transplantation Direct. 2026
Read More
-
Genetic cohorting and therapeutic response in CKD: Real-world insights from RenasightIQ
Watch Video
-
Genetic Testing in the Management of Adult CKD
Chebib, F; et al. Journal of the American Society of Nephrology 2025
Read More
-
Genetics in Practice: Case Review Series with Advanced Practice Providers
Watch Video
-
Prospera in Practice: Nursing Strategies for "High-risk" Results
Watch Video
-
Changing Patient Management with Renasight Kidney Gene Panel
Read More
-
2025 APOL1 Conference Report
Ojo, et al. Kidney International 2025
Read More
-
With Renasight, You'll Know
Watch Video
-
Clinician's Guide- Prospera Heart (Peds)
Read More
-
Clinician's Guide- Prospera Lung
Read More
-
Clinician's Guide- Prospera Heart
Read More
-
Clinician's Guide- Prospera Kidney
Read More
-
Vertex Sponsored Testing- One Pager
Read More
-
Prospera Kidney PEDAL Case Study Booklet
Read More
-
APOL1 Kidney Disease: KDIGO 2025 Controversies Conference Summary
Read More
-
Prospera in Practice: Nursing Strategies for High-Risk Cases
Watch Video
-
Beyond Biopsy: Cell-free DNA is not just to rule out rejection
Watch Video
-
PEDAL Study: Prospera™ dd-cfDNA use in post-rejection monitoring
Watch Video
-
Tumor-informed ctDNA assay to predict recurrence in locally advanced squamous-cell carcinoma of the head and neck (SCCHN)
Honoré N, et al. ESMO 2025
Read More
-
Loading More...
